How China's healthcare advances are opening new doors to the world

From Shanghai's bustling biomedical innovation parks and Hainan's international medical tourism pilot zone to the headquarters of the World Health Organization (WHO) in Geneva, China's healthcare transformation is attracting global attention. The country's evolving health sector is not only reshaping healthcare at home, but also creating new opportunities for international cooperation and global public health.

Biomedical innovation powering growth

China's biomedicine industry is entering a new phase. It has developed into three major innovation hubs – the Yangtze River Delta, the Beijing-Tianjin-Hebei region, and the Guangdong-Hong Kong-Macao Greater Bay Area. Together, they account for more than 80% of the country's industry resources, R&D capacity and market share.

At the heart of the Yangtze River Delta lies Shanghai's Zhangjiang, often referred to as the Pharma Valley of China. Home to more than 4,000 innovation-driven enterprises, 140,000 researchers and a growing network of world-class research institutes, Zhangjiang has become a powerhouse for pharmaceutical innovation, China Media Group (CMG) reports.

Elsewhere, regional strengths continue to emerge. The Greater Bay Area has become a national leader in in-vitro diagnostics and high-end medical devices, while the Chengdu-Chongqing region is building an integrated research-to-manufacturing ecosystem that is driving healthcare innovation in western China.

From a follower to a leader: The power of long-term planning

Huang Xiaojun, an academician of the Chinese Academy of Engineering, told CMG that China has evolved from following global innovators to becoming a major innovator, and even a leader in certain fields.

The numbers reflect that momentum. China conducted more than 1,300 clinical studies in 2025, according to Huang, roughly twelve times the number a decade earlier. As CMG reports, China's National Medical Products Administration approved 76 innovative medicines in 2025 alone, while the country's biomedicine industry reached an estimated market value of five trillion yuan (about $700 billion), representing an annual growth rate of 8.7% and approximately 22% of the global market.

Andy Moose, head of Health Systems Transformation at the World Economic Forum's Center for Health and Healthcare, believes such progress is no coincidence. In an interview with CGTN, Moose said China's rapid rise in healthcare innovation is rooted in years of strategic planning. From the Healthy China 2030 initiative to successive Five-Year Plans, he noted, the country has established a long-term policy framework that aligns government priorities, industry investment and scientific research.

Recognizing the industry's strategic importance, China's 2026 Government Work Report identified biomedicine as one of the country's emerging pillar industries. Regulatory reforms have also accelerated clinical trial approvals by 30 to 40%, reducing development costs while boosting confidence among innovators and investors alike, according to CMG.

Opening China's healthcare sector to the world

Innovation has been accompanied by greater openness. Established in 2013, the Boao Lecheng International Medical Tourism Pilot Zone in Hainan Province has become China's only special medical zone, designed to provide faster access to cutting-edge medicine, medical devices and healthcare services from around the world.

By the end of 2025, the zone had introduced more than 530 internationally approved drugs and medical devices that had not yet entered the broader Chinese market, benefiting more than 200,000 patients, according to the Hainan provincial government.

Demand continues to surge. During the first ten months of 2025, the number of patients using these special medical products increased by 137% year on year, while medical tourism visits rose by more than 80%, the local government states.

Today, the Boao Lecheng International Medical Tourism Pilot Zone is emerging as a gateway connecting global medical innovation with China's vast healthcare market while giving patients faster access to advanced therapies.

A key contributor to global public health security

China's efforts in improving healthcare have extended beyond its borders. As the country continues opening its healthcare sector, it is also expanding its role in global health governance.

In June 2026, China's State Council Information Office released a white paper titled "More Just and Equitable Global Governance: China's Principles, Proposals and Actions," reaffirming the country's commitment as an active and engaged participant in global health affairs. According to the white paper, over the years, China has signed health cooperation agreements with more than 160 countries and international organizations, established multiple regional health cooperation mechanisms, and dispatched more than 30,000 medical workers to 77 countries and regions, providing treatment to over 300 million patients.

China has also participated in major international health responses, including efforts to combat Ebola, while supporting the WHO's central coordinating role in global health governance.

From scientific breakthroughs to stronger international partnerships, China's healthcare transformation is demonstrating how innovation at home can generate benefits far beyond its borders.